PBMD now up 22% at $1.32. The article below probably the reason.
FBR
Capital Starts Prima Biomed (PBMD) at Outperform
December 3, 2015 7:03 AM
FBR Capital initiates coverage on Prima Biomed (NASDAQ: PBMD) with a Outperform rating and a price target of $6.00.
Analyst Vernon Bernardino commented, "We are initiating coverage of Prima BioMed Ltd. (PBMD) with an Outperform rating and a price target of $6 per share. Whereas PBMD had one active clinical program in 2014, the company now has three novel product candidates in active clinical development, including IMP321, IMP731, and GSK 2831781, with the latter two rapidly being advanced by two partners committed to their full evaluation. We believe the current valuation of Prima BioMed is disconnected from our estimation of the significant value PBMD has created in advancing its clinical-stage product pipeline."
For an analyst ratings summary and ratings history on Prima Biomed click here. For more ratings news on Prima Biomed click here.
Shares of Prima Biomed closed at $1.08 yesterday.
PRR Coverage and Pre-Market
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.3¢ |
Change
0.048(16.1%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 33.5¢ | $2.006M | 5.647M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 50263 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 166742 | 5 |
View Market Depth
| Last trade - 10.22am 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |